We further confirmed that inhibition of the STAT3 pathway by STAT3-specific shRNA or LY5 [67, 68] sensitized K-Ras mutated cancer cells to MEK inhibitor treatment in vitro and in vivo. Here, STAT3 is linked to cancer.